"The solution will enable enhanced resource sharing across J&JPRD's global pharmaceutical research & development organizations and will support scores of new Grid applications running at improved performance levels", stated Ben Rouse, United Devices CEO. "Our Grid MP solution has a strong track record of success among pharmaceutical companies like J&JPRD due to its robust functionality, its flexibility and ease of management, its proven ability to scale, and its track record in producing significant cost savings."
"United Devices understands the importance of technology innovation in life sciences", observed Jikku Venkat, United Devices CTO. "The capabilities we will be delivering will provide J&JPRD with increased compute power across clusters, workstations, and PCs. In addition, they will benefit from insights into IT capacity at a global level. United Devices is honoured to be working with J&JPRD on this innovative project."
Under the terms of the agreement, United Devices will deliver Unified Job Scheduling and Capacity Management products with the core Grid infrastructure. The progressive implementation over the next 12-15 months allows J&JPRD to build its infrastructure over time in a planned, controlled manner.
United Devices' Grid MP platform is used to aggregate compute resources from workstations and laptops to servers and clusters on a network to create an enterprise Grid capable of running a wide range of high-performance computing applications in life sciences, geosciences, manufacturing, financial services, chemical engineering and other industries. United Devices also operates the world's largest Grid for grand-scale research that consists of over three million desktop, portable and server systems in more than 220 countries and territories. More company news can be found in the VMW February 2004 article United Devices' Global Grid surpasses 2,5 million connected devices in fight against cancer and smallpox.